Cash & equivalents decreased 35.6%
Cash & equivalents changed -35.6% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -35.6% from the comparable as-filed period.
Net income changed -64.9% from the comparable as-filed period.
Operating income changed -69.6% from the comparable as-filed period.
Operating margin changed -2240 basis points from the comparable as-filed period.
Revenue changed -49.5% from the comparable as-filed period.
Inventory changed +15.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed -6.2% from the comparable as-filed period.
Research & development changed -0.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.